What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Cell biology, Rab, Biochemistry, Endosome and RAB27.
His Cell biology research is multidisciplinary, incorporating elements of Microvesicles, Vesicular transport protein, Immune system, Antigen and Melanosome.
The study incorporates disciplines such as Transport protein, Prenylation and Choroideremia in addition to Rab.
His Endosome research is multidisciplinary, incorporating perspectives in Exosome and Nocodazole.
His study in Exosome is interdisciplinary in nature, drawing from both Secretion, Cancer research, Exosomal secretion and Immunology.
His work deals with themes such as Ras superfamily, Melanophilin and Melanosome transport, which intersect with RAB27.
His most cited work include:
- Rab27a and Rab27b control different steps of the exosome secretion pathway (1303 citations)
- Rab27a and Rab27b control different steps of the exosome secretion pathway (1303 citations)
- Rab27a and Rab27b control different steps of the exosome secretion pathway (1303 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cell biology, Rab, Choroideremia, GTPase and Biochemistry.
Miguel C. Seabra has included themes like Retinal pigment epithelium, Secretion and Melanosome in his Cell biology study.
His Retinal pigment epithelium research incorporates themes from Phagosome and Pathology.
His research investigates the connection between Rab and topics such as Prenylation that intersect with issues in Stereochemistry and GTP-binding protein regulators.
His Choroideremia research includes elements of Retinal degeneration and Genetic enhancement.
His studies in GTPase integrate themes in fields like GTP', Guanosine triphosphate and Effector.
He most often published in these fields:
- Cell biology (93.70%)
- Rab (58.15%)
- Choroideremia (37.78%)
What were the highlights of his more recent work (between 2015-2021)?
- Cell biology (93.70%)
- Retinal (19.63%)
- Choroideremia (37.78%)
In recent papers he was focusing on the following fields of study:
Miguel C. Seabra mainly investigates Cell biology, Retinal, Choroideremia, Ophthalmology and Retinal pigment epithelium.
His biological study focuses on Rab.
The concepts of his Rab study are interwoven with issues in Proteome, Proteomics and Geranylgeranylation.
Miguel C. Seabra interconnects Macular degeneration and Pathology in the investigation of issues within Retinal.
His Choroideremia research is multidisciplinary, relying on both Retinal degeneration, Retina and Genetic enhancement.
His Retinal pigment epithelium research incorporates elements of Endoplasmic reticulum, Inner ear, Basal and Osmotic shock.
Between 2015 and 2021, his most popular works were:
- Visual Acuity after Retinal Gene Therapy for Choroideremia (133 citations)
- Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia (72 citations)
- Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia (72 citations)
In his most recent research, the most cited papers focused on:
Cell biology, Endocytic cycle, Choroideremia, Genetic enhancement and Visual acuity are his primary areas of study.
His Cell biology research integrates issues from Microvesicles, ATG5 and Immune system.
His research in Endocytic cycle intersects with topics in Parasite load, Liver infection, Intracellular parasite and Plasmodium berghei.
His studies deal with areas such as Clinical endpoint, Clinical trial and Cohort as well as Choroideremia.
His work carried out in the field of Genetic enhancement brings together such families of science as Retinal degeneration, Optometry, Microperimetry and Adverse effect.
His Visual acuity study combines topics from a wide range of disciplines, such as Retinal pigment epithelium, Retina and Phases of clinical research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
